13-20414206-TACACACACACAC-TACACACAC
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_015974.3(CRYL1):c.634-823_634-820delGTGT variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.71 ( 37690 hom., cov: 0)
Consequence
CRYL1
NM_015974.3 intron
NM_015974.3 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.523
Publications
0 publications found
Genes affected
CRYL1 (HGNC:18246): (crystallin lambda 1) The uronate cycle functions as an alternative glucose metabolic pathway, accounting for about 5% of daily glucose catabolism. The product of this gene catalyzes the dehydrogenation of L-gulonate into dehydro-L-gulonate in the uronate cycle. The enzyme requires NAD(H) as a coenzyme, and is inhibited by inorganic phosphate. A similar gene in the rabbit is thought to serve a structural role in the lens of the eye. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP6
Variant 13-20414206-TACAC-T is Benign according to our data. Variant chr13-20414206-TACAC-T is described in ClinVar as Benign. ClinVar VariationId is 1271792.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.744 is higher than 0.05.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_015974.3. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CRYL1 | TSL:1 MANE Select | c.634-823_634-820delGTGT | intron | N/A | ENSP00000298248.7 | Q9Y2S2-1 | |||
| CRYL1 | TSL:1 | c.568-823_568-820delGTGT | intron | N/A | ENSP00000372262.1 | Q9Y2S2-2 | |||
| CRYL1 | c.595-823_595-820delGTGT | intron | N/A | ENSP00000557682.1 |
Frequencies
GnomAD3 genomes AF: 0.706 AC: 106230AN: 150374Hom.: 37680 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
106230
AN:
150374
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.706 AC: 106284AN: 150492Hom.: 37690 Cov.: 0 AF XY: 0.704 AC XY: 51710AN XY: 73450 show subpopulations
GnomAD4 genome
AF:
AC:
106284
AN:
150492
Hom.:
Cov.:
0
AF XY:
AC XY:
51710
AN XY:
73450
show subpopulations
African (AFR)
AF:
AC:
25584
AN:
40968
American (AMR)
AF:
AC:
10844
AN:
15138
Ashkenazi Jewish (ASJ)
AF:
AC:
2604
AN:
3456
East Asian (EAS)
AF:
AC:
3288
AN:
5072
South Asian (SAS)
AF:
AC:
3566
AN:
4728
European-Finnish (FIN)
AF:
AC:
7267
AN:
10212
Middle Eastern (MID)
AF:
AC:
210
AN:
292
European-Non Finnish (NFE)
AF:
AC:
50725
AN:
67648
Other (OTH)
AF:
AC:
1489
AN:
2072
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
1526
3053
4579
6106
7632
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
820
1640
2460
3280
4100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
ClinVar submissions
View on ClinVar Significance:Benign
Revision:criteria provided, single submitter
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.